Lisata Therapeutics, Inc. (LSTA) stock
LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.21−0.07 (-5.47%)
Close on Nov 13, 2026Market cap $10.90MP/E –Yield –
Lisata Therapeutics cash
Cash and short-term investments held at the end of each period.
Lisata Therapeutics's cash was $282.72M at Sep 30, 2026. For fiscal 2025 it was $15.96M, down 37.8% from the year before. Over ten years it grew 8.8% a year on average. The highest annual figure on record is $91.45M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.96M | -37.8% |
| FY2024 | Dec 31, 2024 | $25.65M | -42.6% |
| FY2023 | Dec 31, 2023 | $44.66M | -31.0% |
| FY2022 | Dec 31, 2022 | $64.74M | -29.2% |
| FY2021 | Dec 31, 2021 | $91.45M | +197.5% |
| FY2020 | Dec 31, 2020 | $30.74M | +35.0% |
| FY2019 | Dec 31, 2019 | $22.77M | -39.8% |
| FY2018 | Dec 31, 2018 | $37.82M | -27.1% |
| FY2017 | Dec 31, 2017 | $51.89M | +1072.1% |
| FY2016 | Dec 31, 2016 | $4.43M | -35.6% |
| FY2015 | Dec 31, 2015 | $6.88M | -69.2% |
| FY2014 | Dec 31, 2014 | $22.36M | -51.5% |
| FY2013 | Dec 31, 2013 | $46.13M | +235.8% |
| FY2012 | Dec 31, 2012 | $13.74M | +249.0% |
| FY2011 | Dec 31, 2011 | $3.94M | -74.8% |
| FY2010 | Dec 31, 2010 | $15.61M | +118.1% |
| FY2009 | Dec 31, 2009 | $7.16M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $282.72M | +1850.8% |
| Q2 FY2026 | Jun 30, 2026 | $10.44M | -39.5% |
| Q1 FY2026 | Mar 31, 2026 | $13.06M | -43.2% |
| Q4 FY2025 | Dec 31, 2025 | $15.96M | -37.8% |
| Q3 FY2025 | Sep 30, 2025 | $14.49M | -52.2% |
| Q2 FY2025 | Jun 30, 2025 | $17.25M | -49.0% |
| Q1 FY2025 | Mar 31, 2025 | $22.98M | -41.4% |
| Q4 FY2024 | Dec 31, 2024 | $25.65M | -42.6% |
| Q3 FY2024 | Sep 30, 2024 | $30.30M | -40.7% |
| Q2 FY2024 | Jun 30, 2024 | $33.83M | -36.7% |
| Q1 FY2024 | Mar 31, 2024 | $39.22M | -29.4% |
| Q4 FY2023 | Dec 31, 2023 | $44.66M | -31.0% |
| Q3 FY2023 | Sep 30, 2023 | $51.07M | -24.2% |
| Q2 FY2023 | Jun 30, 2023 | $53.41M | -23.4% |
| Q1 FY2023 | Mar 31, 2023 | $55.58M | -35.7% |
| Q4 FY2022 | Dec 31, 2022 | $64.74M | -29.2% |
| Q3 FY2022 | Sep 30, 2022 | $67.33M | -30.6% |
| Q2 FY2022 | Jun 30, 2022 | $69.69M | -31.8% |
| Q1 FY2022 | Mar 31, 2022 | $86.42M | -19.2% |
| Q4 FY2021 | Dec 31, 2021 | $91.45M | +197.5% |
| Q3 FY2021 | Sep 30, 2021 | $96.98M | +156.7% |
| Q2 FY2021 | Jun 30, 2021 | $102.21M | +213.4% |
| Q1 FY2021 | Mar 31, 2021 | $106.92M | +527.6% |
| Q4 FY2020 | Dec 31, 2020 | $30.74M | +35.0% |
| Q3 FY2020 | Sep 30, 2020 | $37.78M | +41.6% |
| Q2 FY2020 | Jun 30, 2020 | $32.61M | +6.1% |
| Q1 FY2020 | Mar 31, 2020 | $17.04M | -52.8% |
| Q4 FY2019 | Dec 31, 2019 | $22.77M | -39.8% |
| Q3 FY2019 | Sep 30, 2019 | $26.69M | -34.4% |
| Q2 FY2019 | Jun 30, 2019 | $30.75M | -23.1% |
| Q1 FY2019 | Mar 31, 2019 | $36.12M | -14.5% |
| Q4 FY2018 | Dec 31, 2018 | $37.82M | -27.1% |
| Q3 FY2018 | Sep 30, 2018 | $40.70M | -27.6% |
| Q2 FY2018 | Jun 30, 2018 | $39.98M | -28.3% |
| Q1 FY2018 | Mar 31, 2018 | $42.27M | +374.1% |
| Q4 FY2017 | Dec 31, 2017 | $51.89M | +1072.1% |
| Q3 FY2017 | Sep 30, 2017 | $56.24M | – |
| Q2 FY2017 | Jun 30, 2017 | $55.77M | – |
| Q1 FY2017 | Mar 31, 2017 | $8.92M | – |
| Q4 FY2016 | Dec 31, 2016 | $4.43M | – |
See a number that looks wrong?